RSV Clinical Trials: Shaping the Future of Respiratory Healthcare

Learn More

In the search for medical breakthroughs, FOMAT Medical Research is committed to understanding and treating Respiratory Syncytial Virus (RSV). Through our clinical trials, we aim to develop new treatments and prevention methods for RSV.

What is Respiratory Syncytial Virus (RSV)?

Definition and RSV in Healthcare

Respiratory Syncytial Virus (RSV) is a common virus that causes respiratory tract infections. It is particularly severe in infants, the elderly, and those with weakened immune systems.

How is RSV spread?

RSV is spread through droplets when an infected person coughs or sneezes. It can also be spread by touching a surface contaminated with the virus and then touching your face.

Young female patient in the clinic suffered from pneumonia, she is coughing the doctor listens to the wheezing in the lungs with a stethoscope.
Suffering from cold. Unhappy cheerless man coughing into his hand while suffering from cold

Symptoms of RSV Infections

RSV infections often present with symptoms similar to a cold, including:

  • Runny nose
  • Loss of appetite
  • Coughing
  • Sneezing
  • Fever
  • Wheezing In severe cases, it can lead to bronchiolitis or pneumonia, especially in young children and the elderly.

Risk Factors

Some people are more at risk of severe RSV infection:

  • Infants under 6 months old
  • Premature infants
  • Children with chronic lung disease or congenital heart disease
  • Immunocompromised individuals
  • Adults over 65 years old
  • People with compromised immune systems

Why Clinical Trials are Important for RSV Research

Why Clinical Trials are Important for RSV Research

  • Test the safety and efficacy of new antiviral drugs and vaccines
  • Develop innovative treatments to reduce the severity of RSV infections
  • Improve preventative measures to protect high-risk populations

By joining RSV trials, you contribute to research that can lead to big medical breakthroughs. Participants get access to the latest treatments and help public health

By participating in RSV trials, individuals contribute to groundbreaking research that can lead to significant medical advancements. Participants often gain access to the latest treatments and play a vital role in improving public health

Our Active Clinical Research Studies

  • Oxnard, Salinas

    Respiratory Syncytial Virus (RSV)

    Participate in an RSV vaccine study to combat lung infections. Help us understand vaccine effects in diverse health conditions. Eligibility criteria apply.

    Criteria & Qualifications: • Must be 18 years or older and diagnosed with RSV within the last 5 days.
    • Experiencing new or worsening symptoms like cough or shortness of breath within 5 days before randomization.
    • Either aged 65+, or have chronic lung disease, heart failure, or an immunosuppressive condition.

    Compensation: Contact us for more information

    Read more
Check our Active Studies!

Frequently Asked Questions

The length of a clinical trial can vary greatly depending on many factors, such as the disease and the medication being tested. For example trials for chronic conditions require participants to be observed for a longer period to assess the long term effects of the treatment. Antibiotic trials are usually short, the treatment period for participants is usually just a few days.

Depending on the study and the process, in some cases you will have to monitor yourself, in other cases you won’t, but you will have the support and guidance of the research team.

Yes. Although the purpose of the study is not to treat an individual for any health condition, a study may involve clinical procedures such as an MRI, blood tests, hearing tests etc. To complete these and other tests the researcher needs to know the volunteer’s general state of health to ensure their safety during the clinical study process..

Yes. Although the purpose of the study is not to treat an individual for any health condition, a study may involve clinical procedures such as an MRI, blood tests, hearing tests etc. To complete these and other tests the researcher needs to know the volunteer’s general state of health to ensure their safety during the clinical study process.

No, you don’t have to be a US citizen to join a clinical trial. We don’t ask for your social security number. All we ask is that you have a physical address and some form of ID that we can use during the enrollment process.

Yes, you can bring a friend or family member to the study, click here for more information!

Who is FOMAT Medical Research?

FOMAT Medical Research is California’s largest research site network, dedicated to advancing clinical research and improving patient outcomes. With multiple research sites and a passion for innovation through diversity, FOMAT Medical Research partners with industry Sponsors and CROs to speed up the development of new treatments across multiple therapeutic areas. FOMAT is a founding member of hyperCORE International, a network of fully professionalized research site organizations.

FOMAT's Commitment to RSV Research

FOMAT Medical Research is driving RSV research. Our expertise in conducting clinical trials enables us to make significant strides in understanding and combating this virus. We invite individuals, sponsors, and healthcare professionals to join us in our mission to advance RSV research.

Check Our Capabilities!

Meet Our Experts

Augusto Focil, M.D., M.P.H.

Augusto Focil, M.D., M.P.H.

Internist
Centered Icon and Text
Oxnard, CA
Betterimage.ai_1721247004587

Preeti Chopra, M.D.

Allergist-Immunologist
Centered Icon and Text
Ventura, CA
Kamlesh Desai, M.D.

Kamlesh Desai, M.D.

Family Doctor
Centered Icon and Text
Santa Maria, CA
Oguchi Nkwocha, M.D.

Oguchi Nkwocha, M.D.

Family Doctor
Centered Icon and Text
Salinas, CA
Meet Our Medical Experts